Brought to you by 
Astellas Pharma, Mitokyne sign drug discovery deal
01 Dec 2017
Executive Summary
Astellas Pharma Inc. and Mitokyne Inc. signed a deal for the discovery, development, and commercialization of drugs designed to improve mitochondrial function, Mitokyne’s area of expertise.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes M&A Option
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Astellas Pharma, Mitokyne sign drug discovery deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice